PAINKILLING ASSOCIATION COMPRISING A DIHYDROIMIDAZOPYRAZINE DERIVATIVE
The invention relates to a product comprising (1R)-1-[(({2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl) -2-phenyl-5,6-dihydroimidazo [1,2-a]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl) -2-phenyl-5,6-dihydrolmidazo[1,2-a]pyrazin-7(8H)-yl]-2-oxoethylamine in association with an analgesic agent selected from morphine, the similar or a morphine derivative, sodium channel inhibitors, non-steroidal antiflammatory agents (AINS), glutamatergic system inhibitors, tricycle antidepressants and gabaergic derivatives for simultaneous therapeutic use which is separated or out over the time for pain treatment or prevention.
1 . Product comprising (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-3-oxopropyl}dithio) methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-2-oxoethylamine or a pharmaceutically acceptable salt thereof and an analgesic agent including ligands of opiate receptors or salts thereof.
2 . Product according to claim 1 , comprising (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-3-oxopropyl}dithio) methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-2-oxoethylamine or a pharmaceutically acceptable salt thereof and morphine or an analogues or derivatives thereof.
3 . Product according to claim 1 , wherein the ligands of opiate receptors or their salts are naloxone, naltrexone, nalorphine, fentanyl, alfentanil, codeine, dihydrocodeine, hydrocodone, oxycodone, hydromorphone, pethidine, remifentanyl, sufentanyl, dextropropoxyphene, tramadol, buprenorphine, nalbuphine, morphine, morphine sulphate, hydromorphone hydrochloride, coated morphine sulphate, or morphine derivatives.
4 . Product according to claim 1 , comprising (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl -5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-2-oxoethylamine or a pharmaceutically acceptable salt thereof and naloxone or naltrexone.
5 . Product according to claim 2 , consisting of (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-3-oxopropyl}dithio) methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-2-oxoethylamine or a pharmaceutically acceptable salt thereof and morphine.
6 . The method according to claim 15 , comprising administering the combination simultaneously.
7 . The method according to claim 15 , comprising administering the combination separately.
8 . The method according to claim 15 , comprising administering the combination spread out over time.
9 . The method according to 14 , wherein the pain treated is pain associated with a cancer, pain associated with chronic diseases other than a cancer, neuropathic pain, pain associated with radiculopathies, with diabetic neuropathies or associated with AIDS or following AIDS, or anticancer agents, inflammatory pain, adiposis dolorosa, pain associated with burns, migraine, pre-operative pain, post-operative pain, chronic inflammatory pain, sciatica, post-herpetic neuralgias, fibromyalgia, algoneurodystrophy or complex regional pain syndrome, central pain following cerebral vascular accidents, thalamic lesions or multiple sclerosis or physical pain or pain associated with intoxication.
10 . The method according to claim 9 , wherein the pain treated is associated with a cancer.
11 . The method according to claim 9 , wherein the pain treated is associated with a chronic disease other than a cancer.
12 . Product according to claim 1 , wherein the ligands of opiate receptors or salts thereof are morphine or morphine derivatives, sodium channel inhibitors, non-steroidal anti-inflammatories (NSAID), glutamatergic system inhibitors, tricyclic antidepressants or GABAergic derivatives.
13 . The method according to claim 9 , wherein the physical pain is pain associated with trauma or amputations.
14 . A method for prevention or treating of pain comprising administering a product comprising (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-3-oxopropyl}dithio) methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo [1,2-α]pyrazin-7(8H)-yl]-2-oxoethylamine or a pharmaceutically acceptable salt thereof in combination with an analgesic agent including ligands of opiate receptors or salts thereof.
15 . The method of claim 14 , comprising administering the combination simultaneously, separate or spread out over time.